The HaP-T1 syrian golden hamster pancreatic cancer model: Cell implantation is better than tissue implantation

Pancreas

Volumn 29, Issue 4, 2004, Pages 320-323

  Abraham, Ajit T ^a   Shah, Sudeep R ^a   Davidson, Brian R ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Experimental animal models; HaP T1 cell line; Metastasis; Orthotopic cell implantation; Pancreatic cancer; Syrian golden hamster

Indexed keywords

NITROSAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CANCER INVASION; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PANCREAS CANCER; PANCREAS TUMOR; PERITONEUM METASTASIS; PRIORITY JOURNAL; SYRIAN HAMSTER; TUMOR GROWTH;

EID: 13644261458     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200411000-00012     Document Type: Article

References (13)

1. Molinari M, Helton WS, Espat NJ. Palliative strategies for locally advanced unresectable and metastatic pancreatic cancer. Surg Clin North Am. 2001;81:651-666.
2. Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995;82:111-115.
3. Burris H, Storniolo AM. Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur J Cancer. 1997;33(suppl 1):S18-S22.
4. Cullinan S. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluoroura-cil, doxorubicin, and cisplatin. Cancer. 1990;65:2207-2212.
5. Standop J, Schneider MB, Ulrich A, et al. Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer. Dig Dis. 2001;19:24-31.
6. Pour PM, Wilson RB. Experimental tumours of the pancreas. In: Moosa AR, ed. Tumours of Pancreas. Baltimore: Waverly Press; 1980:37-158.
7. Pour PM, Egami H, Takiyama Y. Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications. Gastroenterology. 1991;100:529-536.
8. Egami H, Tomioka T, Tempero M, et al. Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters. Am J Pathol. 1991;138:557-561.
9. Furukawa T, Fu X, Kubota T, et al. Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res. 1993;53:1204-1208.
10. Kubota T. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem. 1994;56:4-8.
11. Saito S, Nishimura N, Kubota Y, et al. Establishment and characterization of a cultured cell line derived from nitrosamine-induced pancreatic ductal adenocarcinoma in Syrian golden hamsters. Gastroenterol Jpn. 1988;23:183-194.
12. Hruban RH, Petersen GM, Ha PK, et al. Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am. 1998;7:1-23.
13. Morioka CY, Saito S, Ohzawa K, et al. Homologous orthotopic implantation models of pancreatic ductal cancer in Syrian golden hamsters: which is better for metastasis research-cell implantation or tissue implantation? Pancreas. 2000;20:152-157.